News archive for 2018
-
Colorado publishes latest statistics on impact of cannabis legalisation
(Lisbon, 19.12.2018) This news item was published in the EMCDDA’s Cannabis drug policy news on 17.12.2018 In the US state of Colorado, use and sale of cannabis for recreational purposes has been legal since January 2014... Read more >> -
Registration now open for the eighth European drugs summer school
(Lisbon, 18.12.2018) The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces once again next summer to hold the eighth European drugs summer school (EDSS) on ‘Illicit drugs... Read more >> -
Board re-elects French member Laura d’Arrigo as Chair and Austrian member Franz Pietsch as Vice-Chair
News release No 11/2018 (Lisbon, 14.12.2018) The EMCDDA Management Board, meeting in Lisbon this week, held elections today for the positions of Chair and Vice-Chair of the Board. Read more >> -
Innovative EMCDDA monitoring method sheds light on changes in Europe’s cocaine market
News release No 10/2018 (Lisbon, 13.12.2018) The latest changes in Europe’s cocaine market are explored in a new report published today by the EU drugs agency (EMCDDA). Read more >> -
EMCDDA takes stock of EU-ANSA activities in 2018
(Lisbon, 12.12.2018) This month, the EMCDDA approaches the end of its presidency of the EU Agencies’ Network on Scientific Advice (EU-ANSA) and looks back on a productive year (1). Read more >> -
Signature of working arrangements with five EU agencies
(Lisbon, 06.12.2018) Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) has been significantly strengthened thanks to new legislation applying... Read more >> -
EU drugs agency publishes its first report on the medical use of cannabis
News release No 9/2018 (Lisbon, 04.12.2018) What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue... Read more >> -
Reitox academy: professionalising the prevention workforce through standardised training
(Lisbon, 28.11.2018) Over 50 representatives of the Reitox national focal points (NFPs) and decision-makers from more than 20 countries will gather in Prague this week for a Reitox academy on the theme of prevention (1). Read more >> -
New legislation, bringing faster response to new drugs, applies from today
News release Nº 8/2018 (Lisbon, 23.11.2018) Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) will be significantly strengthened, thanks to new legislation applying... Read more >> -
Canada’s cannabis legalisation enters into force
(Lisbon, 16.11.2018) This news item was published in the EMCDDA’s Cannabis drug policy news on 16.11.2018 Read more >> -
Monitoring drug use in recreational settings across Europe — new report out today
(Lisbon, 15.11.2018) How to build a better picture of substance use in recreational settings is explored today in a new EMCDDA report: Monitoring drug use in recreational settings across Europe: conceptual challenges and... Read more >> -
Annual award celebrates excellence in scientific writing on illicit drugs
News release No 7/2018 (Lisbon, 14.11.2018) Winners of the 2018 EMCDDA scientific award were announced by the EU drugs agency today in the margins of its 49th Scientific Committee meeting in Lisbon (1). The acclaimed writers will be invited to... Read more >> -
2018 Reitox week focuses on ‘futures’
(Lisbon, 13.11.2018) Representatives of candidate, potential candidate and neighbouring countries of the EU and countries of Central Asia are joining members of the EMCDDA’s Reitox network (1) in Lisbon from 12–16... Read more >> -
Prevention technologies — European prevention conference opens today
(Lisbon, 24.10.2018) What do we know about how research evidence is used in the ‘real world’ of prevention? How can we take advantage of technology to promote the use of evidence in policy and practice? What are some of... Read more >> -
Lisbon to host Third European conference on addictive behaviours and dependencies — Registration and call for abstracts now open
(Lisbon, 23.10.2018) Leading international experts in the field of addiction science will meet in Lisbon from 23–25 October 2019 for the Third European conference on addictive behaviours and dependencies. The theme of... Read more >> -
New EMCDDA Paper explores the illicit captagon market
(Lisbon, 22.10.2018) What is captagon? Where is it used and produced? Can it be linked to terrorist attacks in Europe? Read more >> -
Alexis Goosdeel pays official visit to Cyprus
(Lisbon, 10.10.2018) EMCDDA Director Alexis Goosdeel is paying an official visit to Cyprus today, where he is meeting with health and security officials. This is in line with the EMCDDA Strategy 2025, which aims to... Read more >> -
Low-THC cannabis products being sold in the EU – key legal issues
(Lisbon, 09.10.2018) This news item was published in the EMCDDA’s Cannabis drug policy news on 09.10.2018 Read more >> -
EMCDDA and the Republic of Albania strengthen their cooperation
(Lisbon, 03.10.2018) EMCDDA Director Alexis Goosdeel is participating this week in the EU-Western Balkans Ministerial Forum on Justice and Home Affairs, taking place from 4–5 October in Tirana. Read more >> -
EMCDDA Director meets German Drug Commissioner
(Lisbon, 01.10.2018) EMCDDA Director Alexis Goosdeel is paying an official visit to Germany today at the invitation of the Federal Drug Commissioner Marlene Mortler. Discussions will centre on the further development of... Read more >> -
Two new synthetic opioids to be placed under control across the EU
News release No 6/2018 (Lisbon, 28.09.2018) Today, the European Union has decided to subject two new synthetic opioids to control measures across the 28 Member States. The implementing decision of the Council of the EU (1), based on a proposal... Read more >> -
EMCDDA at 3rd Inter-sessional meeting of the UN Commission on Narcotic Drugs
(Lisbon, 25.09.2018) Today, EMCDDA Director Alexis Goosdeel is addressing the 3rd Inter-sessional meeting of the United Nations Commission on Narcotic Drugs (CND) in Vienna. The four-day meeting will focus on: demand... Read more >> -
EMCDDA at 7th International Symposium on Hepatitis Care in Substance Users
(Lisbon, 19.09.2018) This week, the EMCDDA is participating in the 7th International Symposium on Hepatitis Care in Substance Users, organised by the International Network for Hepatitis in Substance Users (INHSU). The... Read more >> -
EMCDDA Director meets President of the European Forum for Urban Security
(Lisbon, 14.09.2018) Director Alexis Goosdeel was in Belgium today where he met with Willy Demeyer, Mayor of Liège and currently President of the European Forum for Urban Security (EFUS). The purpose of the meeting was... Read more >> -
World Hepatitis Day 2018
(Lisbon, 27.07.2018) Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes. The day unites... Read more >> -
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA guidance
(Lisbon, 23.07.2018) People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use. In addition, incarceration... Read more >> -
Alexis Goosdeel meets new Executive Director of Europol
(Lisbon, 17.07.2018) EMCDDA Director Alexis Goosdeel today visited his new counterpart at Europol, Ms Catherine De Bolle in the first official meeting between the two heads of agencies. Read more >> -
Seventh European drugs summer school kicks off in Lisbon with record number of students
(Lisbon, 25.06.2018) The seventh European drugs summer school (EDSS) — ‘Illicit drugs in Europe: demand, supply and public policies’ — opens today in Lisbon on the eve of International day against drug abuse and illicit... Read more >> -
EMCDDA: resurgence of cocaine in a dynamic drug market
News release No 5/2018 (Lisbon, 07.06.2018) Evidence of increased cocaine availability is highlighted by the EMCDDA today in its European Drug Report 2018: Trends and Developments released in Brussels. The development occurs in the context of... Read more >>
